Nitric Acid

Nitric Acid

SCHEMBL1177447

NCC(=O)CCC(=O)OCc1ccccc1.O=[N+]([O-])O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.49
MAPK1 P28482 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
LMNA P02545 2/20 0.45
RAB9A P51151 4/20 0.43
NOTUM Q6P988 1/20 0.42
KMT2A Q03164 3/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 2/20 0.42
NPC1 O15118 2/20 0.42
MITF O75030 1/20 0.42
HTT P42858 1/20 0.42
CCR6 P51684 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
POLB P06746 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1177227 0.91 ALDH1A1 (0.58) ALDH1A1MAPK1L3MBTL1LMNANOTUM
Hydrochloric Acid SCHEMBL1177668 0.90 ALDH1A1 (0.56) ALDH1A1MAPK1L3MBTL1LMNANOTUM
Bromide SCHEMBL1177354 0.90 ALDH1A1 (0.56) ALDH1A1MAPK1L3MBTL1LMNANOTUM
Acetic Acid SCHEMBL27674816 0.87 ALDH1A1 (0.54) ALDH1A1MAPK1L3MBTL1LMNANOTUM
Phosphoric Acid SCHEMBL1177230 0.85 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1LMNARAB9A
Phosphonic Acid SCHEMBL27654802 0.85 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1LMNANOTUM
Sulfuric Acid SCHEMBL1177401 0.85 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1LMNANOTUM
Chloroacetic Acid SCHEMBL19182725 0.84 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1LMNANOTUM
SCHEMBL1177875 0.83 LMNA (0.51) ALDH1A1MAPK1L3MBTL1LMNANOTUM
Dichloroacetic Acid SCHEMBL19182790 0.83 ALDH1A1 (0.49) ALDH1A1MAPK1L3MBTL1LMNANOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2308830-B1 ACID ADDITION SALTS OF 5-AMINOLEVULINIC ACID OR ITS DERIVATIVES PHOTOCURE ASA (NO) 2017-06-14 EP disclosed
US-8692014-B2 Acid addition salts of 5-aminolevulinic acid or its derivatives PHOTOCURE ASA (NO) 2014-04-08 US disclosed
CN-1938264-B Acid addition salts of 5-aminolevulinic acid or derivatives thereof PHOTOCURE ASA 2012-05-23 CN disclosed
US-20110125012-A1 ACID ADDITION SALTS OF 5-AMINOLEVULINIC ACID OR ITS DERIVATIVES BRAENDEN JON ERIK 2011-05-26 US disclosed
EP-2308830-A1 Acid addition salts of 5-aminolevulinic acid or its derivatives Photocure ASA (NO) 2011-04-13 EP disclosed
US-7888526-B2 Nonhygroscopic photosensitizing agents; sulphonate, hydrobromide, sulfate, nitrate and/or phosphate derivatives; diagnosing skin disorders PHOTOCURE ASA (NO) 2011-02-15 US disclosed
US-20080064752-A1 Acid Addition Salts Of-5-Aminolevulinic Acid Or Its Derivatives PHOTOCURE ASA (NO) 2008-03-13 US disclosed
CN-1938264-A Acid addition salts of 5-aminolevulinic acid or derivatives thereof PHOTOCURE ASA (NO) 2007-03-28 CN disclosed
EP-1727786-A1 ACID ADDITION SALTS OF 5-AMINOLEVULINIC ACID OR ITS DERIVATIVES Photocure ASA (NO) 2006-12-06 EP disclosed
WO-2005092838-A1 ACID ADDITION SALTS OF 5-AMINOLEVULINIC ACID OR ITS DERIVATIVES PHOTOCURE ASA (NO) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064752-A1 Acid Addition Salts Of-5-Aminolevulinic Acid Or Its Derivatives ALAD, AASDHPPT, ABAT ALDH1A1 793/4885MAPK1 1719/4885L3MBTL1 2982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.